Search results :

Propafenone

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: C01BC03

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9
Vertigo postmarketing, 21.3% - 23% 14.3% x x x x x x x x x
Dizziness postmarketing, 1.7% - 23% 5% - 14.3% x x x x x x x x x
Upper respiratory tract infection 8.09% - 8.73% 5.56% x x
Body temperature increased 1.9% - 10% x x x x x
Nausea postmarketing, 2% - 16.9% 1% - 8.73% x x x x x x x x x
Vomiting postmarketing, 0.794% - 15% 1% - 3% x x x x x x x x x
Dysgeusia postmarketing, 5.56% - 22.1% 0.794% x x x
Arrhythmia 4.7% x x x x
Constipation postmarketing, 0.2% - 11.8% 0% - 4% x x x x x x x x x
Cardiac murmur 1.59% - 4.41% 0% x x
Ecchymosis 1.59% - 3.68% 0% x x
Haematuria 1.59% - 2.94% 2.38% x x
Cardiac failure congestive 0% - 4% 0.794% x x x x x x x x x
Proarrhythmia 0% - 5% 0% - 1.9% x x x x x x
Angina pectoris 0% - 5% 0% - 1.9% x x x x x x x x x
Dyspepsia 0.9% - 8% x x x x x x x x x
Dyspnoea postmarketing, 0% - 12.7% 2% - 7.14% x x x x x x x x x
Fatigue postmarketing, 1% - 12.5% 5.56% x x x x x x x x x
Headache postmarketing, 0.8% - 10.3% 4.5% - 8.73% x x x x x x x x x
Tinnitus postmarketing, 1.9% - 2% x x x x x x x x x
Vision blurred postmarketing, 0.6% - 6% 0% - 2% x x x x x x x x x
Wide complex tachycardia 1.9% - 2% x x x
Rales 1.59% - 2.21% 0% x x
Somnolence 0.794% - 2.94% 0% x x x
Diarrhoea 0.4% - 39% 0.9% - 5.7% x x x x x x x x x
Ventricular tachycardia postmarketing, 1% - 3.4% x x x x x x
Atrioventricular block first degree 0% - 2.94% 0% - 5% x x x x x x x x x
Cardioactive drug level above therapeutic 0.794% - 2.21% 0.794% x x
Blood alkaline phosphatase increased 0% - 2.94% 0% x x
Dry mouth postmarketing, 0.2% - 6% 0.794% - 2% x x x x x x x x
Asthenia postmarketing, 0.6% - 4.41% 2.38% x x x x x x x x x
Wheezing 0% - 2.21% 0% x x
Abdominal pain postmarketing, 0.4% - 8% x x x x x x x x x
Cramp muscle postmarketing, 0.4% - 8% x x x x x x x x x
Anorexia 0% - 2% 0.9% - 2% x x x x x x x x x
Anxiety postmarketing, 0.5% - 11.8% 1.8% - 10.3% x x x x x x x x x
Atrial fibrillation 0.4% - 1% x x x x
Atrioventricular block postmarketing, 0.3% - 3% x x x x
Bundle branch block 0% - 2% 0% - 1.9% x x x x x x x
Chest pain postmarketing, 0.2% - 2% x x x x x x x x x
Drowsiness 0.2% - 1.2% x x x x x
Oedema 0.2% - 7.35% 6.35% x x x x x x x
Rash postmarketing, 0.6% - 3% x x x x x x x
Palpitations postmarketing, 0.2% - 3.4% 1% - 2.4% x x x x x x x x x
Syncope postmarketing, 0.7% - 2.2% x x x x x x x x x
Ventricular extrasystoles 0.1% - 2% x x x x x x x
Bradycardia postmarketing, 0.2% - 4.41% 0.794% x x x x x x x x x
Presyncope 0.7% - 2.2% x x x
Sweating increased 0.3% - 1.4% x x x x x x x
Abnormal vision postmarketing, 1.9% x x x x x x x
Muscular weakness postmarketing, 0.735% - 0.794% 0% x x x x x x x x x
Antinuclear antibody positive postmarketing, 0.7% x x x x x x x
Hypotension postmarketing, 0% - 1.1% x x x x x x x x x
Tremor 0% - 2.21% 0.794% x x x x x x x x
Convulsion postmarketing, 0.3% x x x x x x x
Insomnia 0% - 2% x x x x x x x
Ataxia postmarketing, 0% - 2% x x x x x x x x x
Flatulence 0% - 2.38% 0% - 1.9% x x x x x x x x
Cholestasis postmarketing, 0.1% x x x x x x x
Pain 0% - 1% x x x x x x x x
Defect conduction intraventricular postmarketing, 0% - 1.1% 0% - 4% x x x x x x x
Agranulocytosis postmarketing x x x x x x x
Alopecia postmarketing x x x x x x x x x
Anaemia postmarketing x x x x x x x x x
Apnoea postmarketing x x x x x x x
Atrial flutter postmarketing, 0% - 2.38% 0.794% x x x x
Atrioventricular dissociation postmarketing x x x x x x x
Mental disorder postmarketing x x x
Breast disorder postmarketing x x x
Coma postmarketing x x x x x x x
Confusional state postmarketing x x x x x x x
Connective tissue disorder postmarketing x
Contusion postmarketing x x x x x x x
Depression postmarketing, 0% - 0.794% 1.59% x x
Eye disorder postmarketing x x x
Cardiac flutter postmarketing x
Gastrointestinal disorder postmarketing x x x
Block heart postmarketing x x
Cardiac disorder postmarketing x
Cardiac failure postmarketing x
Blood disorder postmarketing x
Hypersensitivity postmarketing x x x
Hyponatraemia postmarketing x x x x x x x x x
Orthostatic hypotension postmarketing x
Immune system disorder postmarketing x
Inappropriate antidiuretic hormone secretion postmarketing x x x x x x x
Jaundice postmarketing x x x
Leukopenia postmarketing x x x x x x x
Systemic lupus erythematosus postmarketing x x x x x x
Mediastinal disorder postmarketing x x x
Nephrotic syndrome postmarketing x x x x x x x
Nervous system disorder postmarketing x x x
Numbness postmarketing x x x x x x x
Paraesthesia postmarketing x x x x x x x x x
Pruritus postmarketing x x x x x x x x x
Psychotic disorder postmarketing x x x x x x x
Purpura postmarketing x x x x x x x
Renal failure postmarketing x x x x x x x x x
Tachycardia postmarketing x
Supraventricular tachycardia postmarketing x
Thrombocytopenia postmarketing x x x x x x x x x
Erythema postmarketing x x x
Urinary tract disorder postmarketing x x x
Urticaria postmarketing x x x x x
Angiopathy postmarketing x x x
Ventricular fibrillation postmarketing x x x x
Sinus bradycardia postmarketing x x x
Atrial arrhythmia postmarketing x
Hepatic function abnormal postmarketing x
Bleeding time prolonged postmarketing x x x x x x x
Gamma-glutamyltransferase increased postmarketing x
Hepatocellular injury postmarketing x x x x x x x
Liver function test abnormal postmarketing x x
Aspartate aminotransferase increased postmarketing x x x
Alanine aminotransferase increased postmarketing x x x
Malnutrition postmarketing x x x
Unspecified disorder of skin and subcutaneous tissue postmarketing x x x
Digestion impaired postmarketing x
Decreased appetite postmarketing x
Speech impairment NOS postmarketing x x x x x x x
Abnormal dreams postmarketing x x x x x x x
Eye irritation postmarketing x x x x x x x
Paroxysmal atrial fibrillation postmarketing x x
Erectile dysfunction postmarketing x x x x x x x x x
Conduction disorder postmarketing x x x
Hepatobiliary disease postmarketing x x x
Hepatitis fulminant postmarketing x x x
Mania postmarketing x x x x x x x
Hot flush postmarketing x x x x x x x
Memory loss postmarketing x x x x x x x
Blood and lymphatic system disorders postmarketing x x x
Ear and labyrinth disorders postmarketing x x x
Sperm count decreased postmarketing x
Glucose increased postmarketing x x x x x x x
Lupus-like syndrome postmarketing x
Hepatitis postmarketing, 0.03% x x x x x x x
Gastroenteritis postmarketing, 0% - 2% 1.9% x x x x x x x
Abdominal distension x x
Amnesia x x
Angina unstable x x
Sinus arrhythmia x x
Arthritis x x
Atelectasis x x
Eyelid ptosis x x
Blister x
Bone disorder x x
Bursitis x x
Carotid bruit x x
Neck pain x x
Infection x
Cough x x
Libido decreased x x
Dysphagia x x
Dehydration x x
Dermatitis x x
Diabetes mellitus x x
Diuresis x
Duodenitis x x
Dysuria x x
Emotional disturbance NOS x x
Endophthalmitis x x
Eosinophilia x x
Epistaxis x x
Eructation x x
Oesophagitis 0% - 2% 1.9% x x x
Eye haemorrhage x x
Flushing x x x x x x x x
Gastritis x x
Gastrooesophageal reflux disease x x
Gingival bleeding x x
Glossodynia x x
Glossitis x x
Glycosuria x x
Gout x x
Breath odour x x
Cardiac arrest x x x x x x x x
Haematoma x x
Haemoptysis x x
Haemorrhage x x
Hepatomegaly x x
Hypercholesterolaemia x x
Hyperglycaemia x x
Hyperlipidaemia x x
Hypertension x x
Hypertensive crisis x x
Hypoaesthesia x x
Hypokalaemia x x
Influenza x x
Intestinal obstruction x x
Arthropathy x x
Bundle branch block left x x
Lung disorder x x
Chronic obstructive pulmonary disease x x
Breast pain x x
Melaena x x
Miosis x x
Hypertonia x x
Nervousness x
Neurosis x x
Nightmare x x
Nocturia x x
Oliguria x x
Pallor x x
Pancreatitis x x
Peptic ulcer x x
Pericarditis x x
Neuropathy peripheral x x
Petechiae x x
Pleural effusion x x
Proteinuria x x
Pyuria x x
Retinal disorder x x
Rhinitis x x
Sciatica x x
Sick sinus syndrome x x x x x x
Sinoatrial block x x
Muscle spasms x x
Speech disorder x x
Spleen disorder x x
Cerebrovascular accident x x
Tendonitis x x
Thrombosis x x
Costochondritis x x
Torsade de pointes x x x
Pollakiuria x x
Urinary incontinence x x
Venous thrombosis x x
Weight increased x x
Weight decreased x x
Urinary retention x x
Peripheral vascular disorder x x
Bundle branch block right x x
Mouth ulceration x x
Prothrombin level increased x x
Electrocardiogram QT prolonged x
Dry skin x x
Haemoglobin decreased x x
Ketonuria x x
Malaise x x
Myalgia x x
Visual acuity reduced x x
Dry throat x
Blood creatinine increased x x
Pulse abnormal x x
Urine abnormality x x
Hepatic enzyme increased x x x x x x
Pain in jaw x x
Throat tightness x x
Heart rate irregular x
Respiratory sounds decreased x x
Gingival pain x x
Pulmonary congestion x x
Throat sore x x
Prostatism x x
Collagen-vascular disease x x
Nodal arrhythmia x x
Atrioventricular block second degree 0% - 1.2% x x x x
Rectal haemorrhage x x
Brain injury x x
Peripheral coldness x x
Blood bilirubin increased x x
Atrial hypertrophy x x
Ventricular hypertrophy x x
Extrasystoles x x
Platelet count decreased x x
Red blood cell count decreased x x
Labile blood pressure x x
QRS complex x
Lymphadenopathy x x
Blood pressure increased x x
Dementia x x
Electrocardiogram abnormal x
Paralysis x x
Sinus arrest x x x x x x x x
Monocyte count increased x x
Gait disturbance x x
Heart sounds abnormal x x
Blood glucose increased x x
White blood cell count increased x x
Hyperlactacidaemia x x
Infestation NOS x
Sleep disorder x x
Embolism arterial (limb) x x
Nail abnormality NOS x x
Blood triglycerides increased x x
Blood prolactin increased x x
Respiratory failure x x
Hearing impaired x x
Coronary artery disease x x
Eosinophil count increased x x
Feeling hot x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

PROPAFENONE

Side effects:76
Source:FDA Structured Product Label

Propafenone

Side effects:90
Source:FDA Structured Product Label

PROPAFENONE

Side effects:90
Source:FDA Structured Product Label

PROPAFENONE HYDROCHLORIDE / PMS-PROPAFENONE

Side effects:92
Source:Health Canada

PROPAFENONE HYDROCHLORIDE / RYTHMOL TAB 300MG

Side effects:93
Source:Health Canada

RYTMONORM RYTMONORM 300mg / Rytmonorm, Tablet

Side effects:115
Source:Medsafe

PROPAFENONE

Side effects:212
Source:FDA Structured Product Label

PROPAFENONE

Side effects:223
Source:FDA Structured Product Label

Color scheme:

standardalternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label